left-caret
Insights

tomorrows global business

Life Sciences & Antitrust: 3 Cases to Watch in 2018

January 26, 2018

By Paul Hastings Professional

Life Sciences & Antitrust: 3 Cases to Watch in 2018

The intersection of complex drug competition frameworks and antitrust laws continues to grow, with increased collaboration between the U.S. FDA and FTC on the horizon. Hear from our lawyers on three cases to watch in 2018.